First published several decades ago, the "S. Gastrointestinal and Liver Disease" textbook has undergone numerous revisions and updates to reflect the changing landscape of gastroenterology and hepatology. The 12th edition continues this tradition, offering a thorough and engaging review of the current state of knowledge in the field. The textbook has become a trusted companion for medical students, residents, and practicing gastroenterologists and hepatologists worldwide.
: Features new and expanded discussions on MASLD (metabolic dysfunction-associated steatotic liver disease), eosinophilic disorders, and the array of new treatments for IBD . s gastrointestinal and liver disease 12th edition
, provides a comprehensive two-volume update on the pathophysiology, diagnosis, and management of GI and liver conditions. Key Features and Updates First published several decades ago, the "S
: Guided by a new senior team including Drs. Raymond T. Chung, David T. Rubin, and C. Mel Wilcox. Decision-Making Tools : Includes over 1,100 full-color illustrations The textbook has become a trusted companion for
Often referred to simply as Sleisenger and Fordtran’s , the 12th edition remains the definitive, encyclopedic reference for physicians, fellows, and residents in gastroenterology and hepatology. Published in 2020 by Elsevier, this two-volume set continues the legacy of providing comprehensive, evidence-based, and clinically actionable information on the entire spectrum of digestive disorders. The 12th edition arrives at a time of rapid advancements in gut microbiome research, immunotherapy for liver disease, and minimally invasive endoscopic techniques, all of which are thoroughly integrated into this update.
